PHARM-INTER
0427.154.841 · rovalta.com · 21/09/2026
PHARM-INTER
Overview
What does PHARM-INTER do?
PHARM-INTER is a Private limited company incorporated in 1984. Its main activity is: Wholesale of pharmaceutical goods. Its registered office is in Koekelberg. It employs on average 3,4 ETP workers (FTE).
1081 Koekelberg · BruxellesSee on map
Joint committees (1)
- 226
Trend over 20 financial years
| 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 | 2007 | 2006 | ||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Income statement | |||||||||||||||||||||||||||||||||||||||
| Gross margin | 1,2 M € | +34.4% | 874,6 k € | -8.8% | 959,4 k € | +28.6% | 745,8 k € | -2.7% | 766,5 k € | +3.5% | 740,5 k € | +59.2% | 465,2 k € | +24.9% | 372,4 k € | -21.3% | 473,4 k € | +12.3% | 421,6 k € | +12.6% | 374,3 k € | -15.3% | 442,1 k € | -10.7% | 494,8 k € | -4.4% | 517,6 k € | -6.7% | 554,9 k € | +18.9% | 466,6 k € | -8.6% | 510,5 k € | +67.3% | 305,1 k € | +8.2% | 282,1 k € | +6.6% | 264,7 k € |
| EBITDA | 517,2 k € | -13.6% | 598,9 k € | +315% | 144,4 k € | -71.1% | 499,7 k € | -9.4% | 551,5 k € | +12.2% | 491,6 k € | +152% | 194,9 k € | +68.9% | 115,4 k € | -50.4% | 232,7 k € | +22.0% | 190,7 k € | +19.7% | 159,3 k € | -22.5% | 205,5 k € | -23.4% | 268,2 k € | -14.9% | 315,2 k € | +5.0% | 300,2 k € | +64.3% | 182,8 k € | -31.9% | 268,5 k € | +176% | 97,3 k € | +8.5% | 89,7 k € | +5.2% | 85,2 k € |
| Operating result | 504,6 k € | -13.5% | 583,5 k € | -13.8% | 676,6 k € | +159% | 261 k € | -29.9% | 372,5 k € | +18.5% | 314,4 k € | +87.0% | 168,1 k € | +96.0% | 85,8 k € | -59.0% | 209,3 k € | +21.3% | 172,6 k € | +28.6% | 134,2 k € | -25.6% | 180,5 k € | -26.0% | 243,8 k € | -11.9% | 276,9 k € | +15.3% | 240,1 k € | +68.4% | 142,5 k € | -25.1% | 190,3 k € | +248% | 54,7 k € | +22.8% | 44,5 k € | +14.3% | 39 k € |
| Net result | 307 k € | -10.9% | 344,7 k € | -22.0% | 442,2 k € | +57.5% | 280,7 k € | +7.4% | 261,5 k € | +31.2% | 199,2 k € | +190% | 68,8 k € | -29.2% | 97,1 k € | +47.5% | 65,8 k € | -37.7% | 105,7 k € | -5.8% | 112,2 k € | +7.9% | 103,9 k € | -16.1% | 123,9 k € | -0.8% | 124,9 k € | +34.0% | 93,3 k € | -21.2% | 118,3 k € | +68.7% | 70,2 k € | +819% | 7,6 k € | +151% | -14,9 k € | -169% | 21,6 k € |
| Balance sheet | |||||||||||||||||||||||||||||||||||||||
| Equity | 933,1 k € | +9.0% | 856,1 k € | -0.6% | 861,4 k € | +12.0% | 769,2 k € | +24.4% | 618,5 k € | +22.0% | 507,1 k € | +24.3% | 407,8 k € | -2.7% | 419 k € | +0.7% | 415,9 k € | -3.3% | 430,1 k € | -2.0% | 438,6 k € | -39.6% | 726,4 k € | +0.5% | 722,5 k € | +3.4% | 698,6 k € | +6.9% | 653,7 k € | +2.1% | 640,4 k € | +6.4% | 602,1 k € | +13.2% | 532 k € | +1.5% | 524,3 k € | -2.8% | 539,2 k € |
| Total assets | 7,7 M € | -1.1% | 7,8 M € | +3.8% | 7,5 M € | +39.1% | 5,4 M € | +4.4% | 5,2 M € | +16.1% | 4,5 M € | +30.9% | 3,4 M € | -10.2% | 3,8 M € | +38.6% | 2,7 M € | +8.1% | 2,5 M € | +12.3% | 2,2 M € | -6.3% | 2,4 M € | -1.7% | 2,4 M € | +5.7% | 2,3 M € | -1.4% | 2,3 M € | -24.5% | 3,1 M € | +10.8% | 2,8 M € | +28.2% | 2,2 M € | +19.9% | 1,8 M € | -5.9% | 1,9 M € |
| Cash | 3,2 M € | +131% | 1,4 M € | -27.4% | 1,9 M € | +102% | 952,1 k € | +10.2% | 864,1 k € | +296% | 218,1 k € | +109% | 104,6 k € | -53.0% | 222,5 k € | -68.0% | 695,8 k € | +74.2% | 399,4 k € | -21.3% | 507,4 k € | +7.4% | 472,2 k € | +0.3% | 470,9 k € | +294% | 119,4 k € | +19.9% | 99,6 k € | +427% | 18,9 k € | -77.8% | 85 k € | +29.6% | 65,6 k € | +83.5% | 35,7 k € | +90.2% | 18,8 k € |
| Debts | 6,8 M € | -2.3% | 6,9 M € | +4.3% | 6,6 M € | +43.6% | 4,6 M € | +1.7% | 4,6 M € | +15.4% | 3,9 M € | +31.8% | 3 M € | -11.1% | 3,4 M € | +45.4% | 2,3 M € | +10.5% | 2,1 M € | +15.8% | 1,8 M € | +8.1% | 1,7 M € | -2.7% | 1,7 M € | +6.7% | 1,6 M € | -4.5% | 1,7 M € | -31.4% | 2,5 M € | +12.0% | 2,2 M € | +33.0% | 1,7 M € | +27.4% | 1,3 M € | -7.2% | 1,4 M € |
| Other | |||||||||||||||||||||||||||||||||||||||
| Workforce | 3,4 ETP | 0.0% | 3,4 ETP | 0.0% | 3,4 ETP | 0.0% | 3,4 ETP | +6.2% | 3,2 ETP | -11.1% | 3,6 ETP | -14.3% | 4,2 ETP | +7.7% | 3,9 ETP | +14.7% | 3,4 ETP | +3.0% | 3,3 ETP | 0.0% | 3,3 ETP | 0.0% | 3,3 ETP | 0.0% | 3,3 ETP | 0.0% | 3,3 ETP | -10.8% | 3,7 ETP | -9.8% | 4,1 ETP | 0.0% | 4,1 ETP | +5.1% | 3,9 ETP | -4.9% | 4,1 ETP | 0.0% | 4,1 ETP |
Indicative valuation
As an indication, this company is worth
Board of directors
Seen on filing of 31/12/2025 · 1 active · 1 ended
Active mandates
Ended mandates
Other companies at this address
| Company | CBE no. |
|---|---|
ATHENA MANAGEMENT COMPANY● Active | 0746.757.963 |
Financials
Full financial information
| 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | |
|---|---|---|---|---|---|---|
| Type of account | Abridged model | Abridged model | Abridged model | Abridged model | Abridged model | Abridged model |
| Start of the financial year | 01/01/2025 | 01/01/2024 | 01/01/2023 | 01/01/2022 | 01/01/2021 | 01/01/2020 |
| Closing of the financial year | 31/12/2025 | 31/12/2024 | 31/12/2023 | 31/12/2022 | 31/12/2021 | 31/12/2020 |
| Length of the financial year | 12 months | 12 months | 12 months | 12 months | 12 months | 12 months |
| Filing date | 21/05/2026 | 26/05/2025 | 29/05/2024 | 24/05/2023 | 05/07/2022 | 07/06/2021 |
| General meeting | 20/05/2026 | 21/05/2025 | 15/05/2024 | 17/05/2023 | 18/05/2022 | 19/05/2021 |
| Currency of the financial year | EUR | EUR | EUR | EUR | EUR | EUR |
| NBB quality label | Satisfying controls | Satisfying controls | Satisfying controls | Satisfying controls | Satisfying controls | Satisfying controls |
Financial ratios
Looking for more information about this company?
Try for 7 daysAnnual accounts filings
20 filings with the NBB
| Model | Closing | General meeting | Filed | Language | Document |
|---|---|---|---|---|---|
| Abridged model | 31/12/2025 | 20/05/2026 | 21/05/2026 | French | |
| Abridged model | 31/12/2024 | 21/05/2025 | 26/05/2025 | French | |
| Abridged model | 31/12/2023 | 15/05/2024 | 29/05/2024 | French | |
| Abridged model | 31/12/2022 | 17/05/2023 | 24/05/2023 | French | |
| Abridged model | 31/12/2021 | 18/05/2022 | 05/07/2022 | French | |
| Abridged model | 31/12/2020 | 19/05/2021 | 07/06/2021 | French | |
| Abridged model | 31/12/2019 | 30/06/2020 | 13/07/2020 | French | |
| Abridged model | 31/12/2018 | 25/06/2019 | 05/07/2019 | French | |
| Abridged model | 31/12/2017 | 29/06/2018 | 09/07/2018 | French | |
| Abridged model | 31/12/2016 | 17/05/2017 | 29/05/2017 | French | |
| Abridged model | 31/12/2015 | 24/06/2016 | 07/07/2016 | French | |
| Abridged model | 31/12/2014 | 19/06/2015 | 24/06/2015 | French | |
| Abridged model | 31/12/2013 | 13/06/2014 | 20/06/2014 | French | |
| Abridged model | 31/12/2012 | 14/06/2013 | 27/06/2013 | French | |
| Abridged model | 31/12/2011 | 16/05/2012 | 01/06/2012 | French | |
| Abridged model | 31/12/2010 | 18/05/2011 | 14/06/2011 | French | |
| Abridged model | 31/12/2009 | 19/05/2010 | 25/06/2010 | French | |
| Abridged model | 31/12/2008 | 20/05/2009 | 12/06/2009 | French | |
| Abridged model | 31/12/2007 | 21/05/2008 | 05/06/2008 | French | |
| Abridged model | 31/12/2006 | 16/05/2007 | 20/06/2007 | French |
Valuation
Indicative valuation
As an indication, this company is worth
between 2,5 M€ and 5 M€
The detail comes with the Business plan: low and high bounds, the valuation bridge for each financial year, transaction multiples by sector and size, group valuation and exports.
Indicative estimate based on public sector multiples and the filed annual accounts. It is neither a certified valuation nor financial or investment advice.
Directors & structure
Board of directors
Seen on filing of 31/12/2025 · 1 active · 1 ended
Active mandates
Ended mandates
Ownership and network
Looking for more information about this company?
Try for 7 daysPublications
Belgian Official Gazette publications
- Mandates09/11/2023STATUTS (TRADUCTION, COORDINATION, AUTRES MODIFICATIONS, ) - MODIFICATION FORME JURIDIQUE - DEMISSIONS, NOMINATIONS
- Capital / shares08/05/2015CAPITAL, ACTIONS - STATUTS (TRADUCTION, COORDINATION, AUTRES MODIFICATIONS, )
- Capital / shares01/10/2013CAPITAL, ACTIONS
- Capital / shares11/12/2012CAPITAL, ACTIONS - ASSEMBLEE GENERALE - STATUTS (TRADUCTION, COORDINATION, AUTRES MODIFICATIONS, )
Source: Belgian Official Gazette
Similar companies
Similar companies
A company's peers, by sector and size, are included in the Business plan.
See the Business planTimeline
Timeline
- 2025Annual accounts 2025307 k €↓
- 2025Name changePHARMA INTER SRL
- 2024Annual accounts 2024344,7 k €↓
- 2023Annual accounts 2023442,2 k €↑
- 2022Annual accounts 2022280,7 k €↑
- 2021Annual accounts 2021261,5 k €↑
- 2021Name changePHARM INTER
- 2020Annual accounts 2020199,2 k €↑
- 2019Annual accounts 201968,8 k €↓
- 2018Annual accounts 201897,1 k €↑
- 2017Annual accounts 201765,8 k €↓
- 2016Annual accounts 2016105,7 k €↓
- 2015Annual accounts 2015112,2 k €↑
- 2014Annual accounts 2014103,9 k €↓
- 2013Annual accounts 2013123,9 k €↓
- 2012Annual accounts 2012124,9 k €↑
- 2011Annual accounts 201193,3 k €↓
- 2010Annual accounts 2010118,3 k €↑
- 2009Annual accounts 200970,2 k €↑
- 2008Annual accounts 20087,6 k €↑
- 2007Annual accounts 2007-14,9 k €↓
- 2006Annual accounts 200621,6 k €
- 05/09/1984IncorporationPrivate limited company